Pediatric Cancer | CHOP Research Institute
 

Pediatric Cancer

Pediatric Research Awards, Mood Disorders and Driving, Smart Mouthguards

Published on
Apr 12, 2024
in Cornerstone Blog
Accelerating Research Careers, Mood Disorders, and More
This week, AACR names CHOP physician-scientists as grant recipients, and CIRP researchers publish new findings on driving and mood disorders.

CHOP Researcher Leads Neuroblastoma Guidelines Development

Published on
Mar 25, 2024
in Cornerstone Blog
CHOP Researcher Leads Neuroblastoma Guidelines Development
Rochelle Bagatell, MD, chaired the multidisciplinary panel that developed the NCCN guidelines, which will help to direct treatment of a highly heterogeneous disease.

CHOP Researchers Awarded Cancer Grand Challenges Funding

Published on
Mar 5, 2024
in Cornerstone Blog
Yael Mossé and John Maris
Two global teams are developing solid cancer drugs and understanding T-cell receptors.

Researchers Building Childhood Cancer Isoform Atlas to Find Immunotherapy Targets

Published on
Jan 29, 2024
in Cornerstone Blog
Researchers Building Childhood Cancer Isoform Atlas
With funding from the National Cancer Institute’s Childhood Cancer Data Initiative, CHOP researchers are identifying new immunotherapy targets.

Fludarabine/Cytarabine/Gemtuzumab Ozogamicin With or Without Venetoclax in Relapsed AML

Fludarabine,Cytarabine,Gemtuzumab Ozogamicin With or Without Venetoclax in Relapsed AML

This study involves taking a study drug called venetoclax with or without standard of care chemotherapy.

Holveck Family Gift Expedites Research for Rare Cancers

Published on
Nov 16, 2023
in Cornerstone Blog
Through the Connor Initiative, CHOP researchers are working to unlock novel therapies that will change the standard of care for osteosarcoma.
The Connor Initiative, a multimillion dollar gift from the Holveck Family, will support precision therapeutics for osteosarcoma and rare cancers.

Mitochondria and Cancer Connections (MC²) Research Program

Mitochondria and Cancer Connections (MC²) Research Program

The Mitochondria and Cancer Connections (MC2) Research program leverages knowledge from existing centers to establish a novel, cutting-edge research initiative and enable the development of mechanistic understanding and novel therapeutic opportunities at the intersection of mitochondrial disease and pediatric cancer.

Food Allergies, Telemedicine, Parkway Run, Fungal Disease, Sickle Cell Documentary

Published on
Sep 30, 2022
in Cornerstone Blog
In the News
Learn about novel findings and new grants from Children’s Hospital of Philadelphia researchers.

CHOP Researchers Join Global Team to Take On Solid Cancers

Published on
Jun 29, 2022
in Cornerstone Blog
CHOP Researchers Join Global Team to Take On Solid Cancers
CHOP scientists are part of a Cancer Grand Challenges team receiving $25 million to tackle solid tumors.
Evan Weber, PhD
Evan W. Weber

Dr. Weber is developing approaches to enhance CAR-T cell therapies for pediatric cancer by reprogramming T cells with improved durability and exhaustion resistance. His work will uncover molecular mechanisms that promote CAR-T cell exhaustion and identify new targets for therapeutic intervention.

E-mail:
weberew [at] chop.edu